M G Zurlo - JoVE Visualize

Showing results (1-10 of 19) with videos related to

Pageof 2

Sort By:

Medical and Pediatric Oncology|January 1, 1989

Treating childhood acute lymphoblastic leukaemia (ALL): summary of ten years' experience in Italy. ALL Steering Committee of the Associazione Italiana Ematologia Oncologia Pediatrica (AIEOP)G Paolucci, G Masera, V Vecchi, et al.

Investigational New Drugs|November 1, 1992

Comparative in vitro myelotoxicity of FCE 24517, a distamycin derivative, to human, canine and murine hematopoietic progenitor cellsD A Volpe, D L Du, M G Zurlo, et al.

Archives of Disease in Childhood|January 1, 1988

Insulin dependent diabetes in thalassaemiaV De Sanctis, M G Zurlo, E Senesi, et al.

Medical and Pediatric Oncology|February 1, 1995

Relapse after first cessation of therapy in childhood acute lymphoblastic leukemia: a 10-year follow-up study. Italian Association of Pediatric Hematology-Oncology (AIEOP)R Miniero, P Saracco, G Pastore, et al.

European Journal of Cancer & Clinical Oncology|November 1, 1987

Prospective randomized comparison of two prophylactic regimens with trimethoprim-sulfamethoxazole in leukemic children: a two year studyM R Rossi, P Banfi, M Cappuccilli, et al.

Advances in Experimental Medicine and Biology|January 1, 1982

Clinical relevance of terminal transferase and adenosine deaminase in leukemiaE Brusamolino, U Bertazzoni, P Isernia, et al.

Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 17, 1998

Tallimustine, an effective antileukemic agent in a severe combined immunodeficient mouse model of adult myelogenous leukemia, induces remissions in a phase I studyM Beran, S Jeha, S O'Brien, et al.

Pediatric Hematology and Oncology|January 1, 1988

Height of children off therapy after acute lymphoblastic leukemiaM G Zurlo, E Senesi, B Terracini, et al.

Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 1, 1994

Phase I study of the novel distamycin derivative tallimustine (FCE 24517)C Sessa, O Pagani, M G Zurlo, et al.

Cancer|March 1, 1986

Italian registry of patients off therapy after childhood acute lymphoblastic leukemia. Results after first phase of data collectionM G Zurlo, G Pastore, G Masera, et al.

Pageof 2

Showing results (1-10 of 19) with videos related to

Sort By:

Pageof 2

Medical and Pediatric Oncology|January 1, 1989

Treating childhood acute lymphoblastic leukaemia (ALL): summary of ten years' experience in Italy. ALL Steering Committee of the Associazione Italiana Ematologia Oncologia Pediatrica (AIEOP)G Paolucci, G Masera, V Vecchi, et al.

Investigational New Drugs|November 1, 1992

Comparative in vitro myelotoxicity of FCE 24517, a distamycin derivative, to human, canine and murine hematopoietic progenitor cellsD A Volpe, D L Du, M G Zurlo, et al.

Archives of Disease in Childhood|January 1, 1988

Insulin dependent diabetes in thalassaemiaV De Sanctis, M G Zurlo, E Senesi, et al.

Medical and Pediatric Oncology|February 1, 1995

Relapse after first cessation of therapy in childhood acute lymphoblastic leukemia: a 10-year follow-up study. Italian Association of Pediatric Hematology-Oncology (AIEOP)R Miniero, P Saracco, G Pastore, et al.

European Journal of Cancer & Clinical Oncology|November 1, 1987

Prospective randomized comparison of two prophylactic regimens with trimethoprim-sulfamethoxazole in leukemic children: a two year studyM R Rossi, P Banfi, M Cappuccilli, et al.

Advances in Experimental Medicine and Biology|January 1, 1982

Clinical relevance of terminal transferase and adenosine deaminase in leukemiaE Brusamolino, U Bertazzoni, P Isernia, et al.

Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 17, 1998

Tallimustine, an effective antileukemic agent in a severe combined immunodeficient mouse model of adult myelogenous leukemia, induces remissions in a phase I studyM Beran, S Jeha, S O'Brien, et al.

Pediatric Hematology and Oncology|January 1, 1988

Height of children off therapy after acute lymphoblastic leukemiaM G Zurlo, E Senesi, B Terracini, et al.

Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 1, 1994

Phase I study of the novel distamycin derivative tallimustine (FCE 24517)C Sessa, O Pagani, M G Zurlo, et al.

Cancer|March 1, 1986

Italian registry of patients off therapy after childhood acute lymphoblastic leukemia. Results after first phase of data collectionM G Zurlo, G Pastore, G Masera, et al.

Pageof 2